Drug Approval | August 20, 2024
Granules India receives ANDA approval for Glycopyrrolate Oral Solution
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
The approval for Glycopyrrolate clears the path for more internally manufactured injectable products
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device
Subscribe To Our Newsletter & Stay Updated
